These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24699435)
41. Cancer epigenetics. Taby R; Issa JP CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400 [TBL] [Abstract][Full Text] [Related]
42. Epigenome: a new target in cancer therapy. Giacinti L; Vici P; Lopez M Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037 [TBL] [Abstract][Full Text] [Related]
43. Cancer control and prevention: nutrition and epigenetics. Verma M Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):376-84. PubMed ID: 23676683 [TBL] [Abstract][Full Text] [Related]
44. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation. Reamon-Buettner SM; Borlak J Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910 [TBL] [Abstract][Full Text] [Related]
45. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Kumar M; Nagpal R; Verma V; Kumar A; Kaur N; Hemalatha R; Gautam SK; Singh B Nutr Rev; 2013 Jan; 71(1):23-34. PubMed ID: 23282249 [TBL] [Abstract][Full Text] [Related]
46. Role of epigenetic events in chemical carcinogenesis--a justification for incorporating epigenetic evaluations in cancer risk assessment. Koturbash I; Beland FA; Pogribny IP Toxicol Mech Methods; 2011 May; 21(4):289-97. PubMed ID: 21495867 [TBL] [Abstract][Full Text] [Related]
47. Rewiring the solid tumor epigenome for cancer therapy. Braun CJ; Hemann MT Expert Rev Anticancer Ther; 2016 Sep; 16(9):977-87. PubMed ID: 27410491 [TBL] [Abstract][Full Text] [Related]
48. Targeting epigenetic regulatory mechanisms in cancer chemoprevention. Fay JR; Crowell JA; Kopelovich L Expert Opin Ther Targets; 2005 Apr; 9(2):315-28. PubMed ID: 15934918 [TBL] [Abstract][Full Text] [Related]
49. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy. Conte M; Fontana E; Nebbioso A; Altucci L Mar Drugs; 2020 Dec; 19(1):. PubMed ID: 33396307 [TBL] [Abstract][Full Text] [Related]
50. Botanicals as epigenetic modulators for mechanisms contributing to development of metabolic syndrome. Kirk H; Cefalu WT; Ribnicky D; Liu Z; Eilertsen KJ Metabolism; 2008 Jul; 57(7 Suppl 1):S16-23. PubMed ID: 18555849 [TBL] [Abstract][Full Text] [Related]
51. Cancer control and prevention by nutrition and epigenetic approaches. Verma M Antioxid Redox Signal; 2012 Jul; 17(2):355-64. PubMed ID: 22047027 [TBL] [Abstract][Full Text] [Related]
52. Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach. Uramova S; Kubatka P; Dankova Z; Kapinova A; Zolakova B; Samec M; Zubor P; Zulli A; Valentova V; Kwon TK; Solar P; Kello M; Kajo K; Busselberg D; Pec M; Danko J EPMA J; 2018 Dec; 9(4):403-419. PubMed ID: 30538792 [TBL] [Abstract][Full Text] [Related]
53. New and under explored epigenetic modulators in search of new paradigms. Alam MA; Reddy YS; Ali MA Med Chem; 2015; 11(3):271-85. PubMed ID: 25256243 [TBL] [Abstract][Full Text] [Related]
54. Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic Opportunities. Lauschke VM; Barragan I; Ingelman-Sundberg M Annu Rev Pharmacol Toxicol; 2018 Jan; 58():161-185. PubMed ID: 29029592 [TBL] [Abstract][Full Text] [Related]
56. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds. Vidoni C; Ferraresi A; Secomandi E; Vallino L; Dhanasekaran DN; Isidoro C Semin Cancer Biol; 2020 Nov; 66():34-44. PubMed ID: 31054926 [TBL] [Abstract][Full Text] [Related]
57. Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression. Ratovitski EA Curr Genomics; 2017 Apr; 18(2):175-205. PubMed ID: 28367075 [TBL] [Abstract][Full Text] [Related]
58. Natural Plant Extracts as Potential Therapeutic Agents for the Treatment of Cancer. Goyal S; Gupta N; Chatterjee S; Nimesh S Curr Top Med Chem; 2017; 17(2):96-106. PubMed ID: 27237328 [TBL] [Abstract][Full Text] [Related]
59. [Cell complexity should be placed at the heart of cancer research]. Goud B; Louvard D Med Sci (Paris); 2018 Jan; 34(1):63-71. PubMed ID: 29384098 [TBL] [Abstract][Full Text] [Related]
60. Epigenetic field defects in progression to cancer. Bernstein C; Nfonsam V; Prasad AR; Bernstein H World J Gastrointest Oncol; 2013 Mar; 5(3):43-9. PubMed ID: 23671730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]